These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 17459021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.
    Jianfeng G, Weiming Z, Ning L, Fangnan L, Li T, Nan L, Jieshou L.
    J Surg Res; 2005 Aug; 127(2):177-82. PubMed ID: 15921697
    [Abstract] [Full Text] [Related]

  • 3. [Serum citrulline: a potential marker for intestinal epithelial mass and absorption capacity in short bowel syndrome patients].
    Gong JF, Zhu WM, Li N, Liu FN, Tan L, Luo N, Li JS.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):333-7. PubMed ID: 17659456
    [Abstract] [Full Text] [Related]

  • 4. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity.
    Peters JH, Wierdsma NJ, Teerlink T, van Leeuwen PA, Mulder CJ, van Bodegraven AA.
    Am J Gastroenterol; 2007 Dec; 102(12):2814-9. PubMed ID: 17764491
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 6. Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure.
    Picot D, Garin L, Trivin F, Kossovsky MP, Darmaun D, Thibault R.
    Clin Nutr; 2010 Apr; 29(2):235-42. PubMed ID: 19744750
    [Abstract] [Full Text] [Related]

  • 7. Plasma citrulline concentration as a marker for disease activity in patients with Crohn's disease.
    Elkhatib I, Buchman AL.
    J Clin Gastroenterol; 2012 Apr; 46(4):308-10. PubMed ID: 21897281
    [Abstract] [Full Text] [Related]

  • 8. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 9. Comparison of different measurements of intestinal permeability in inflammatory bowel disease.
    Howden CW, Robertson C, Duncan A, Morris AJ, Russell RI.
    Am J Gastroenterol; 1991 Oct; 86(10):1445-9. PubMed ID: 1928036
    [Abstract] [Full Text] [Related]

  • 10. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
    Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA.
    Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
    [Abstract] [Full Text] [Related]

  • 11. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome.
    Santarpia L, Catanzano F, Ruoppolo M, Alfonsi L, Vitale DF, Pecce R, Pasanisi F, Contaldo F, Salvatore F.
    Ann Nutr Metab; 2008 Mar; 53(2):137-42. PubMed ID: 18997462
    [Abstract] [Full Text] [Related]

  • 12. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.
    Crenn P, Messing B, Cynober L.
    Clin Nutr; 2008 Jun; 27(3):328-39. PubMed ID: 18440672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 15. Increased intestinal permeability in patients with inflammatory bowel disease.
    Welcker K, Martin A, Kölle P, Siebeck M, Gross M.
    Eur J Med Res; 2004 Oct 29; 9(10):456-60. PubMed ID: 15546811
    [Abstract] [Full Text] [Related]

  • 16. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
    Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T.
    Scand J Gastroenterol; 2005 Sep 29; 40(9):1058-65. PubMed ID: 16165718
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Citrulline and intestinal fatty acid-binding protein: longitudinal markers of postweaning small intestinal function in pigs?
    Berkeveld M, Langendijk P, Verheijden JH, Taverne MA, van Nes A, van Haard P, Koets AP.
    J Anim Sci; 2008 Dec 29; 86(12):3440-9. PubMed ID: 18708596
    [Abstract] [Full Text] [Related]

  • 20. [Intestinal permeability in relatives of patients with Crohn's disease].
    Kohout P, Koref P.
    Vnitr Lek; 2001 Jun 29; 47(6):371-4. PubMed ID: 11494882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.